Moderna Inc (MRNA)
$146.42
1.93 (1.30%)
MRNA Stock Quote Delayed 30 Minutes
7 Blue-Chip Stocks Sitting in the Sweet Spot
Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
56.37B
PE Ratio
7.32
EPS
20.01
Volume (Avg. Vol.)
1.36M
Day's Range
$146.18 - $149.66
52-Week Range
$115.03 - $217.25
Dividend & Yield
N/A (N/A)
MRNA Stock Predictions, Articles, and Moderna Inc News
I Asked ChatGPT for 10 Meme Stocks to Buy. Here’s What It Recommended.
I asked ChatGPT to define what makes a meme stock a meme stock. I also tasked it with picking out some of its favorites.
NVAX Stock Alert: Is Novavax Going Bankrupt?
NVAX stock is tanking after the pharma company said it might not be able to continue operations as sales of its Covid-19 vaccine are weak.
Why Is Moderna (MRNA) Stock Down 5% Today?
If Moderna's new formulation works the latest failure will be a short-term hiccup. But MRNA stock also faces legal and PR challenges.
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
Moderna (MRNA) stock is on the move Wednesday alongside positive results from its latest Phase 3 mRNA-1345 vaccine trial.
CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal
CytomX Therapeutics announced a licensing deal with Moderna, which may supercharge the underlying ambitions of CTMX stock.
Moderna (MRNA) Stock Soars on Cancer Vaccine News
Moderna (MRNA) stock is rising higher on Tuesday following the release of data from a Phase 2B cancer vaccine clinical trial.
Why Is Moderna (MRNA) Stock Down 5% Today?
Moderna (MRNA) stock is falling on Thursday following the release of the vaccine company's earnings report for the third quarter of 2022.
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines.
Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today?
Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit?
7 Stocks That Could Sink Your Portfolio if You Don’t Sell Now
Investors should take note. These seven stocks to sell could sink your portfolio if you don't unload them now.
